March 4, 2025 - 02:41

Shares of networking chip designer Marvell Technology experienced a notable decline of 5.9% in the afternoon trading session. This drop coincided with a broader market downturn following the confirmation from the Trump administration regarding the implementation of a 25% tariff on imports from Canada and Mexico. These two nations are among the United States' largest trading partners, and the announcement has amplified existing market anxieties that have been escalating since the beginning of 2025.
The decision to move forward with the tariffs has raised concerns among Wall Street analysts and investors, who are now assessing the potential impact on trade relations and economic stability. Businesses that rely heavily on cross-border trade are particularly apprehensive about the implications of increased costs and potential retaliatory measures. As the situation develops, stakeholders are closely monitoring how these tariffs could affect the overall market and specific sectors, including technology and manufacturing, which are heavily interconnected with international trade dynamics.
February 9, 2026 - 08:29
QuantumScape CTO on Eagle Line and scaling solid-state techThe race to commercialize solid-state batteries, a technology promising safer, longer-range electric vehicles, is entering a critical new phase. A key leader at QuantumScape has detailed the...
February 7, 2026 - 02:44
Getting Our Future Out of Traffic: Boston Pilots Emerging Transportation Technology for School BussesDuring the spring of 2025, Boston Public Schools achieved historic highs in on-time bus performance, hitting 94% in both March and June—a milestone that reflects years of systematic improvements...
February 6, 2026 - 05:07
Microchip Technology (NASDAQ:MCHP) Beats Q4 Sales TargetsAnalog semiconductor leader Microchip Technology has announced financial results that exceeded market expectations for its fourth quarter. The company reported revenue of $1.19 billion, marking a...
February 5, 2026 - 22:23
Commentary urges balance between research integrity and technology transfer in biomedicineAs federal policymakers consider significant changes to the funding and regulation of U.S. biomedical research, a leading scientist emphasizes the critical need to maintain a careful equilibrium....